Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14887-4 Primidone SCnc Ser/Plas Pt Qn     ACTIVE Primidone [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14887-4         Both       0 Primidone SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Mysoline; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               umol/L       0
14888-2 Procainamide SCnc Ser/Plas Pt Qn     ACTIVE Procainamide [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14888-2         Both       0 Procainamide SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; PA; Pl; Plasma; Plsm; Point in time; Procan; Pronestyl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14889-0 Procainamide+N-acetylprocainamide SCnc Ser/Plas Pt Qn     ACTIVE Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14889-0         Both       0 Procainamide+NAPA SerPl-sCnc       Y   Acecainide; Acetylprocanam; DRUG/TOXICOLOGY; Drugs; Level; NAPA; PA; Pl; Plasma; Plsm; Point in time; Procainamide+NAPA; Procan; Pronestyl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
1489-4 Gastrin^5M post 0.2 U/kg secretin MCnc Ser/Plas Pt Qn     ACTIVE Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin   MIN DefinitionDescription     pg/mL             CHAL   1489-4         Observation       0 Gastrin 5M p 0.2 u/kg SCT SerPl-mCnc       Y   5M p 0.2 u/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome 2.34 1               pg/mL       0
14890-8 Progesterone SCnc Ser/Plas Pt Qn     ACTIVE Progesterone [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             CHEM   14890-8         Both       0 Progest SerPl-sCnc       Y   Chemistry; Level; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               nmol/L       0
14891-6 Propranolol SCnc Ser/Plas Pt Qn     ACTIVE Propranolol [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14891-6         Both       0 Propranolol SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Inderal; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14892-4 Propranolol SCnc Urine Pt Qn     ACTIVE Propranolol [Moles/volume] in Urine   MIN DefinitionDescription     nmol/L             DRUG/TOX   14892-4         Both       0 Propranolol Ur-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Inderal; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.42 1.0k               nmol/L       0
14893-2 Propranolol SRat Urine 24H Qn     ACTIVE Propranolol [Moles/time] in 24 hour Urine   MIN DefinitionDescription     nmol/24 H             DRUG/TOX   14893-2         Both       0 Propranolol 24h Ur-sRate       Y   1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Inderal; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.42 1.0k               nmol/(24.h)       0
14894-0 Propylene glycol PrThr Ser/Plas Pt Ord     ACTIVE Propylene glycol [Presence] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   14894-0         Both       0 Prop glycol SerPl Ql           DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prop glycol; Ql; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.56 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14895-7 Protein pattern Imp Ser/Plas Pt Nom Immunofixation   ACTIVE Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation   MIN DefinitionDescription                   CHEM   14895-7   Immunofixation     Observation       0 Prot Pattern SerPl IFE-Imp           Chemistry; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k                       0
14896-5 Protein pattern Imp Urine Pt Nom Immunofixation   ACTIVE Protein Fractions [Interpretation] in Urine by Immunofixation   MIN DefinitionDescription                   CHEM   14896-5   Immunofixation     Observation       0 Prot Pattern Ur IFE-Imp           Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Nephrology; Nominal; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Renal; UA; UR; Urn 2.73 1.0k                       0
14897-3 Protein MCnc Plas Pt Qn     DEPRECATED Deprecated Protein [Mass/volume] in Plasma   DEL DefinitionDescription     g/dL             CHEM   14897-3                 0 Deprecated Prot Plas-mCnc           Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random 2.4 1.0k       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14898-1 Protriptyline SCnc Ser/Plas Pt Qn     ACTIVE Protriptyline [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14898-1         Both       0 Protrip SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vivactil 2.34 1.0k               umol/L       0
14899-9 quiNIDine SCnc Ser/Plas Pt Qn     ACTIVE quiNIDine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14899-9         Both       0 quiNIDine SerPl-sCnc       Y   Chinidine; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
149-5 Cephalexin Susc Isolate Pt OrdQn MIC   ACTIVE Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   149-5   MIC     Observation       0 Cephalexin Islt MIC           ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadine; GRACEF; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflex; Losporal; Minimum inhibitory concentration; Palitrex; Point in time; Random; Salitex; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1                       0
1490-2 Gastrin^pre 0.2 U/kg secretin MCnc Ser/Plas Pt Qn     ACTIVE Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin   MIN DefinitionDescription     pg/mL             CHAL   1490-2         Observation       0 Gastrin pre 0.2 u/kg SCT SerPl-mCnc       Y   Before; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre 0.2 u/kg SCT; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome 2.73 1               pg/mL       0
14900-5 raNITIdine PrThr Gast fld Pt Ord     ACTIVE raNITIdine [Presence] in Gastric fluid   MIN DefinitionDescription                   DRUG/TOX   14900-5         Both       0 raNITIdine Gast Ql           DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Zantac 2.56 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14901-3 raNITIdine PrThr Ser/Plas Pt Ord     ACTIVE raNITIdine [Presence] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   14901-3         Both       0 raNITIdine SerPl Ql           DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zantac 2.56 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14902-1 raNITIdine PrThr Urine Pt Ord     ACTIVE raNITIdine [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   14902-1         Both       0 raNITIdine Ur Ql           DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Zantac 2.73 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14903-9 Folate Imp Bld Pt Nom     ACTIVE Folate [Interpretation] in Blood   MIN DefinitionDescription                   CHEM   14903-9         Observation       0 Folate Bld-Imp           Blood; Chemistry; Folat; Folic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Pteroylglutamate; Pteroylglutamic acid; Random; Vit M; Vitamin M; WB; Whole blood 2.26 1.0k                       0
14904-7 Reagin Ab PrThr XXX Pt Ord VDRL   ACTIVE Reagin Ab [Presence] in Specimen by VDRL   MIN DefinitionDescription                   MICRO   14904-7   VDRL     Both       0 VDRL Spec Ql           ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Microscopic flocculation; Misc; Miscellaneous; Neurosyphilis; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Syphilis; To be specified in another part of the message; Treponema; Unspecified; Venereal Disease Research Laboratory 2.73 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14905-4 Retinol SCnc Ser/Plas Pt Qn     ACTIVE Retinol [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             CHEM   14905-4         Both       0 Vit A SerPl-sCnc       Y   Axerol; Axerophthol; Biosterol; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit A; Vit A alcohol; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A1 2.73 1.0k               umol/L       0
14906-2 Rh Type BldCo Pt Nom     ACTIVE Rh [Type] in Cord blood   MIN DefinitionDescription                   BLDBK   14906-2         Both       0 Rh BldCo           Blood - (umbilical) cord; BLOOD BANK; Cord (umbilical) blood; Cord bld; Cord blood; D phenotyping; D typing; Gyn; Gynecology; Hematology; Heme; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Rh phenotyping; Rh typing; Typ 2.73 1.0k                       0
14907-0 Rh Type Bld^BPU Pt Nom     ACTIVE Rh [Type] in Blood from Blood product unit   MIN DefinitionDescription                   BLDBK   14907-0         Observation       0 Rh Bld BPU           Blood; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); D phenotyping; D typing; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood 2.73 1.0k                       0
14908-8 Rh Type Bld^Newborn Pt Nom     ACTIVE Rh [Type] in Blood from Newborn   MIN DefinitionDescription                   BLDBK   14908-8         Both       0 Rh Bld NB           Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; NB; New born; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood 2.73 1.0k                       0
104,672 results found